In the next 5 years, Excellent launch matters more than ever, because over $200 billion in revenue is at risk from loss of exclusivity by 2030, and pharmaceutical companies must deliver an unprecedented number of launches, with consistently strong performance, to fill that gap and sustain growth.
Looking ahead to 2030, the path to Excellent launch looks different. Some launch fundamentals remain, but there are new types of launch, new critical investments for launch and new rules impacting global launch performance.
Find out the secrets to unlock efficiency, embrace change and thrive in a fast-paced and volatile environment.
How innovators are beating the odds in a high-stakes therapeutic area
How to navigate harsh realities in a highly fluid environment
How patient support programmes can provide the competitive edge in a tough launch landscape
Lessons for Medical Affairs from IQVIA's Launch Excellence research
Achieving commercial launch excellence for the most innovative medicines in areas of high unmet need
How to capture the full potential of a pipeline in a product
Discover proven strategies and insights refined over more than 5,000 launches around the world.
Use a web-based platform to identify crucial pre-launch activities, create and monitor launch plans across your entire global portfolio across different markets
Unique launch strategies to make your products shine
.svg){kind=icon}
